# LAMIVUDINE
> **ANDA205217** · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2014-12-18
## Drug
- **FDA Application Number:** ANDA205217
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LAMIVUDINE
- **Generic name:** LAMIVUDINE
- **Active ingredients:** LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** LUPIN
- **Manufacturer:** Lupin Pharmaceuticals, Inc.
- **First approval:** 2014-12-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205217)
---
*MORVS · CC0 1.0*